Company Product Description Indication Status
Beckman Coulter Diagnostics, of Brea, Calif. Access SARS-CoV-2 IgG assay Antibody test Aids in identifying patients with an adaptive immune response to SARS-CoV-2 Demonstrated its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate Virus Neutralization Test, which detects antibodies that block the interaction between the receptor binding domain (RBD) of the spike (S) protein and the ACE-2 host cell receptor that are necessary for infection; the findings show antibodies that target the RBD of the S protein are potentially neutralizing to the novel coronavirus
Daxor Corp., of New York BVA-100 Diagnostic blood test Provides quantification of blood volume status and composition compared to patient-specific norms Presented data on the use of Daxor's BVA-100 blood test for measuring anemia; showed that true anemia was present in 62% of patients but that commonly-used hemoglobin and hematocrit tests cannot accurately detect this condition in heart failure patients; patients with lengths of stay greater than 10 days (twice the average patient) were also 3 times more likely to suffer from anemia suggesting its significant risk to patients
Guardant Health Inc., of Redwood City, Calif. Guardant360 Liquid biopsy test; analyzes 74 genes using cell-free tumor DNA from blood samples For treatment guidance in patients with metastatic lung cancer The SCRUM-Japan GOZILA study compared comprehensive genomic profiling using the Guardant360 liquid biopsy vs. tissue genotyping for trial enrollment into the SCRUM-Japan study network; patients with advanced gastrointestinal cancer were matched to novel therapies that target the specific biomarkers identified; compared to tissue genotyping (n=5,621) used in GI-SCREEN, the Guardant360 liquid biopsy (n=1,687) shortened screening duration by 67% (median 11 vs. 33 days) and improved trial enrollment rate by 132% (9.5% vs. 4.1%); findings were published in Nature Medicine

Notes

For more information about individual companies and/or products, see Cortellis.